Atıf Formatları
Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. GÜMÜŞLÜ, "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," 16th Congress of the APSR , Shanghai, China, pp.31, 2011

GÜMÜŞLÜ, S. 2011. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. 16th Congress of the APSR , (Shanghai, China), 31.

GÜMÜŞLÜ, S., (2011). Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment . 16th Congress of the APSR (pp.31). Shanghai, China

GÜMÜŞLÜ, SAADET. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment," 16th Congress of the APSR, Shanghai, China, 2011

GÜMÜŞLÜ, SAADET. "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." 16th Congress of the APSR , Shanghai, China, pp.31, 2011

GÜMÜŞLÜ, S. (2011) . "Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment." 16th Congress of the APSR , Shanghai, China, p.31.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment}, congress name={16th Congress of the APSR}, city={Shanghai}, country={China}, year={2011}, pages={31} }